Corrigendum to "Co-delivery of HIF1α siRNA and gemcitabine via biocompatible lipid-polymer hybrid nanoparticles for effective treatment of pancreatic cancer" [Biomaterials 46 (2015) 13-25].

Biomaterials

Department of Pancreatic Carcinoma, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center of Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin, 300060, China. Electronic address:

Published: January 2022

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.biomaterials.2021.121296DOI Listing

Publication Analysis

Top Keywords

corrigendum "co-delivery
4
"co-delivery hif1α
4
hif1α sirna
4
sirna gemcitabine
4
gemcitabine biocompatible
4
biocompatible lipid-polymer
4
lipid-polymer hybrid
4
hybrid nanoparticles
4
nanoparticles effective
4
effective treatment
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!